Docetaxel-related fatigue in men with metastatic prostate cancer: a descriptive analysis.

about

Docetaxel-related fatigue in men with metastatic prostate cancer: a descriptive analysis.

Item

http://www.wikidata.org/entity/Q38827471

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Docetaxel-related fatigue in men with metastatic prostate cancer: a descriptive analysis.

@en

type

Item

label

Docetaxel-related fatigue in men with metastatic prostate cancer: a descriptive analysis.

@en

prefLabel

Docetaxel-related fatigue in men with metastatic prostate cancer: a descriptive analysis.

@en

P1476

Docetaxel-related fatigue in men with metastatic prostate cancer: a descriptive analysis

@en

P2093

A R T Bergin

http://www.w3.org/2001/XMLSchema#string

E Hovey

http://www.w3.org/2001/XMLSchema#string

G Marx

http://www.w3.org/2001/XMLSchema#string

P Parente

http://www.w3.org/2001/XMLSchema#string

P de Souza

http://www.w3.org/2001/XMLSchema#string

T Rapke

http://www.w3.org/2001/XMLSchema#string

P2860

Exercise for the management of cancer-related fatigue in adults

Psychosocial interventions for reducing fatigue during cancer treatment in adults

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer

The validity and utility of the MD Anderson Symptom Inventory in patients with prostate cancer: evidence from the Symptom Outcomes and Practice Patterns (SOAPP) data from the Eastern Cooperative Oncology Group

Impact of medical Qigong on quality of life, fatigue, mood and inflammation in cancer patients: a randomized controlled trial

Cancer-Related Fatigue, Version 2.2015.

Mechanisms of cancer-related fatigue.

Cause of death in older men after the diagnosis of prostate cancer.

P2888

s00520-017-3706-8

P304

2871-2879

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00520-017-3706-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Andrew R. Lloyd

P577

2017-04-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28429147

http://www.w3.org/2001/XMLSchema#string